Withdrawal or reduction of steroids based on pharmacodynamics assessed by antilymphocyte action after renal transplantation.
Kozaki
K
K
Department of Transplantation, Hachioji Medical Center, Tokyo Medical College, Japan.
Takeuchi
H
H
Hirano
T
T
Oka
K
K
Sakurai
E
E
Uchiyama
M
M
Matsuno
N
N
Yoshida
M
M
Kozaki
M
M
D000328:Adult; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011239:Prednisolone / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D011239:Prednisolone; D006854:Hydrocortisone; D008775:Methylprednisolone